シャドーイング練習: Journal Highlight: 30-Day Outcomes of Resolute Onyx Stent for Symptomatic Intracranial Stenosis - 動画で英語スピーキングを学ぶ
レッスンを作成中...
1
we're presenting 30 -day outcome of Resolute Onyx stent for symptomatic
2
intracranial stenosis symptomatic intracranial stenosis is a significant cause of strokes
3
and medically refractory patients have higher recurrence rates the only FDA
4
approved device at this moment in the United States is wingspan stent which is a bare metal stent two randomized trials,
5
Sampras and Casis have demonstrated very high complication rates and no significant relative risk reduction with wingspan stent.
6
Newer generation drug eluting stents have shown promise elsewhere such as NOVA trial.
7
Resolute Onyx is one such stent which has distinct advantages in navigation and lower drug potency.
8
For this multi -center analysis, our key question was, is use of Resolute Onyx stent associated with lower 30 -day risk of major complications in comparison to Sampras data.
9
We included patients with recurrent ischemia and stenosis of 70 % to 99 % on best medical management.
10
Primary outcome was 30 -day composite of stroke, intracerebral hemorrhage, and death.
11
Data from eight comprehensive stroke centers was collected.
12
Propensity match groups were created with Sampras medical and stenting.
13
This investigation was broken up into three different groups, the Resolute Onyx stent group, the Sampras medical management group, the Sampras stenting group.
14
Propensity score match groups were created controlling for age, hyperlipidemia, hypertension, diabetes, and smoking.
15
30 -day complication rate of the Resolute Onyx stent was significantly
16
lower than the stenting arm of Sampras with an odds ratio of 5 .9.
17
The 30 -day complication rate of the Resolute Onyx stent was not statistically different when compared to medical arm of Sampras.
18
In conclusion, patients treated with Resoluonix drug -eluting stent had a decreased rate of 30 -day major complications in comparison to Sampras.
19
Further, large -scale prospective studies are warranted to evaluate the safety and efficacy of Resoluonix for the treatment of symptomatic intracranial atherosclerosis.
20
Given the better safety profile, we will be announcing shortly a prospective multi -center study.
21
Thank you.
22
Thank you.
このレッスンについて
「Journal Highlight: 30-Day Outcomes of Resolute Onyx Stent for Symptomatic Intracranial Stenosis」を使って、シャドーイングで英語を練習しましょう。
毎日15〜30分の練習で、IELTSスピーキングへの自信と実践的な英会話力が身につきます。
シャドーイングとは？英語上達に効果的な理由
シャドーイング（Shadowing）は、もともとプロの通訳者養成プログラムで開発された言語学習法で、多言語習得者として知られるDr. Alexander Arguelles によって広く普及されました。方法はシンプルですが非常に効果的：ネイティブスピーカーの英語を聞きながら、1〜2秒の遅延で声に出してすぐに繰り返す——まるで「影（shadow）」のように話者を追いかけます。文法ドリルや受動的なリスニングと異なり、シャドーイングは脳と口の筋肉が同時にリアルタイムで英語を処理・再現することを強制します。研究により、発音精度、抑揚、リズム、連音、リスニング力、そして会話の流暢さが大幅に向上することが確認されています。IELTSスピーキング対策や自然な英語コミュニケーションを目指す方に特におすすめです。